AI-Powered Personalization for Hair Loss: A Promising Alternative? With up to 50% of women and 80% of men experiencing hair loss, many turn to generic over-the-counter solutions—often with disappointing results.…
JAK Inhibitors in Alopecia Areata: A Case for Persistence? Oral Janus kinase inhibitors (JAKi) have emerged as a promising treatment for severe alopecia areata, with FDA-approved options now available. But…
Trending Article Alopecia is more than just a cosmetic concern - it’s a significant quality-of-life issue for patients with autoimmune connective tissue diseases (ACTDs) such as SLE, MCTD, Sjogren syndrome, UCTD,…
Trichoscopy in Skin of Color: Uncovering Overlapping Alopecia Trichoscopy is a critical tool in diagnosing hair disorders, but findings can vary in skin of color, requiring a tailored approach to…
ICI Therapy and Hair Loss: A Rare but Impactful Side Effect Immune checkpoint inhibitors (ICIs) have transformed cancer treatment, empowering the immune system to target tumors more effectively. But with…
Intralesional Steroids vs. Cryotherapy: Which Wins for Alopecia Areata? Alopecia Areata (AA) remains an enigmatic condition with treatment options offering varying degrees of success. While intralesional corticosteroids are the first-line treatment,…
Patchy Hair Loss: When Alopecia Areata Isn’t the Answer Not all patchy hair loss is alopecia areata. Two recent cases reveal cutaneous lupus erythematosus (CLE) mimicking AA, highlighting a critical…
JDD Article Highlights Scarring alopecia, marked by irreversible hair follicle damage, is notoriously difficult to treat. While immunomodulatory therapies are the cornerstone, emerging evidence suggests platelet-rich plasma (PRP) may help…
JDD Article Highlights This article from November’s JDD study reveals a potential game-changer in the fight against Androgenetic Alopecia (male pattern baldness). Researchers compared two popular treatments for hair regrowth,…